Literature DB >> 32149015

Author Response to Letter to the Editor.

Victoria Castrillo-Fraile1,2, Elena Casas Peña3, José María Trejo Gabriel Y Galán3, Pedro David Delgado-López4, Carla Collazo5, Esther Cubo3,5.   

Abstract

Entities:  

Keywords:  Essential tremor; non-pharmacological treatment; orthesis

Mesh:

Year:  2020        PMID: 32149015      PMCID: PMC7052429          DOI: 10.7916/tohm.v0.770

Source DB:  PubMed          Journal:  Tremor Other Hyperkinet Mov (N Y)        ISSN: 2160-8288


× No keyword cloud information.
Dear Editor: We deeply appreciate the comments provided by López-Blanco et al. regarding our recent publication entitled “Tremor Control Devices for Essential Tremor: A Systematic Literature Review.”[1] We basically agree with the aspects highlighted by these authors; however, we would like to discuss them briefly. First, the main objective of our systematic literature review was to conduct a literature search about tremor-control devices using standardized criteria regarding efficacy and comfort in patients diagnosed with essential tremor (ET). We did not include computer software/hardware to control kinetic tremor by using the mouse of a PC, because the scientific literature supporting this technology have included patients with multiple sclerosis exclusively.[2,3] We also excluded websites that did not include peer-review literature supporting effectiveness.[3] Second, we fully agree with their second statement regarding the lack of publications of negative studies, and independent testing outside the initial developers.[3] It would be interesting to study whether publication bias is more prevalent among nonpharmacologic interventions as compared to drugs in tremor and other neurological related fields.[4] Third, we also agree on the importance of duration of clinical trials aimed to analyze the inherent variability of tremor intensity during testing. In order to study the effectiveness of tremor-suppression devices in ET, the functional impairment should ideally be studied at home, or at least, in a friendly environment, either in a natural/casual setting or under carefully-controlled circumstances in the lab, for a certain amount of time, to reduce tremor fluctuations due to confusing factors (pharmacological treatment effects, anxiety, etc.). We appreciate the above comments provided by López-Blanco et al. which definitively improve the discussion of our article and highlight the importance of well-designed pharmacological and nonpharmacological clinical trials in ET.
  2 in total

1.  Neurology® null hypothesis: A special supplement for negative, inconclusive, or confirmatory studies.

Authors:  Sandra Petty; Robert A Gross
Journal:  Neurology       Date:  2018-06-08       Impact factor: 9.910

2.  Tremor Control Devices for Essential Tremor: A Systematic Literature Review.

Authors:  Victoria Castrillo-Fraile; Elena Casas Peña; José María Trejo Gabriel Y Galán; Pedro David Delgado-López; Carla Collazo; Esther Cubo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.